Hawaiʻi is one of 10 states selected to participate in a program that expands access to comprehensive mental health, ...
Incyte Corp. ( INCY) is close to acquiring privately held Star Therapeutics in a deal valued at up to $2 billion, the ...
Regeneron's EYLEA HD US sales surged 52% in Q1 2026, offsetting competitive pressures and patient switching within the EYLEA ...
Patients express mixed feelings about promising pancreatic cancer drug; FDA’s voucher program gets less-than-perfect reviews; ...
15h
Colorado Springs programs respond to changing attitudes about addiction, though stigma remains high
While attitudes about addiction to drugs and alcohol are changing to reflect more acceptance and understanding, the industry is not keeping pace with the cultural shift, a recent nationwide study ...
Conclusion: ATG-207 represents a differentiated immune tolerance–restoring strategy that integrates precision T cell ...
Ascletis Pharma Inc. (HKEX: 1672, 'Ascletis') announces the presentation of three key studies at the American Diabetes ...
Strategic collaboration combines Nurix’s leadership in targeted protein degradation with Roche’s portfolio of B-cell targeted ...
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results